USD 0.0
(0.0%)
Breakdown | 2021 | 2020 | 2019 |
---|---|---|---|
Operating Cash Flow | -9.18 Million | -1.73 Million | -45.68 Thousand |
Net Income | -4.32 Million | -12.67 Million | -79.12 Thousand |
Depreciation & Amortization | 609.08 Thousand | 30.98 Thousand | - |
Deferred income taxes | -451.18 Thousand | 7.81 Million | - |
Stock-based compensation | 878.83 Thousand | 968.56 Thousand | - |
Change in working capital | -6.96 Million | 1.3 Million | 33.44 Thousand |
Other non-cash items | 1.05 Million | 818.17 Thousand | - |
Investing Cash Flow | -159.89 Thousand | -2.98 Million | - |
Investments in PPE | -159.89 Thousand | -69.2 Thousand | - |
Acquisitions | - | -2.91 Million | - |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | -12.87 Thousand | - | - |
Financing Cash Flow | 10.07 Million | 3.61 Million | 1.35 Million |
Debt repayment | -272.59 Thousand | -401.31 Thousand | - |
Dividends payments | - | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | 10.34 Million | 1.04 Million | 1.17 Million |
Other Financing Activities | - | 2.96 Million | 175.49 Thousand |
Accounts receivables | -7.79 Million | - | - |
Accounts payables | - | - | - |
Inventory | -290.68 Thousand | 263.55 Thousand | - |
Other working capital | -6.67 Million | 1.04 Million | - |
Cash at beginning of period | 200.54 Thousand | 1.3 Million | - |
Cash at end of period | 925.92 Thousand | 200.54 Thousand | 1.3 Million |
Capital Expenditure | -159.89 Thousand | -69.2 Thousand | - |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | 725.37 Thousand | -1.1 Million | 1.3 Million |
Free Cash Flow | -9.34 Million | -1.8 Million | -45.68 Thousand |
Breakdown | 2023 Q4 | 2023 Q2 | 2022 Q2 | 2022 Q1 | 2021 FY | 2021 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | -6.98 Million | -3455.37 | -4.32 Million | -2323.10 |
Depreciation & Amortization | - | - | 429.11 Thousand | 212.18 | 609.08 Thousand | 405.54 |
Deferred income taxes | - | - | - | - | -451.18 Thousand | - |
Stock-based compensation | - | - | 643.66 | 641.38 | 878.83 Thousand | 522.52 |
Change in working capital | - | - | 3.95 Million | 1277.01 | -6.96 Million | -5662.15 |
Other non-cash items | - | - | -1.75 Million | 701.36 | 1.05 Million | 1039.86 |
Investing Cash Flow | - | - | -144.68 Thousand | -71.54 | -159.89 Thousand | -70.29 |
Investments in PPE | - | - | -144.68 Thousand | -71.54 | -159.89 Thousand | -61.39 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | -8.91 |
Financing Cash Flow | - | - | 257.09 Thousand | 127.13 | 10.07 Million | 6673.40 |
Debt repayment | - | - | -270.51 Thousand | - | -272.59 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 135.67 Thousand | - | 10.34 Million | - |
Other Financing Activities | - | - | 127.58 | 127.13 | - | 6673.40 |
Accounts receivables | - | - | 2.46 Million | 1218.12 | - | -5152.40 |
Accounts payables | - | - | 1.37 Million | - | - | - |
Inventory | - | - | 119.08 Thousand | 58.88 | -290.68 Thousand | -509.75 |
Other working capital | - | - | 4.00 | - | -6.67 Million | - |
Cash at beginning of period | - | - | 1.26 Million | - | 200.54 Thousand | - |
Cash at end of period | - | - | 112.57 Thousand | -567.85 | 925.92 Thousand | 585.77 |
Capital Expenditure | - | - | -144.68 Thousand | -71.54 | -159.89 Thousand | -61.39 |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -1.14 Million | -567.85 | 725.37 Thousand | 585.77 |
Free Cash Flow | - | - | -1.4 Million | -694.98 | -9.34 Million | -6078.72 |
GILXF
300709
RECLTD
CLOV
SNI
ARB